-+ 0.00%
-+ 0.00%
-+ 0.00%
Hims & Hers Health CFO Says Hims’ Menopause Therapies, Testosterone Testing Boosted Revenue Per Subscriber For The Third Quarter; Hims Intentionally Paced Marketing Spending For Weight-Loss Drugs In Third Quarter, Ahead Of Expansion
Share
Listen to the news

-Conference Call

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending